Literature DB >> 30808987

CRPC-specific gene therapy.

Louise Stone1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30808987     DOI： 10.1038/s41585-019-0165-7

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Gene therapy for castration-resistant prostate cancer cells using JC polyomavirus-like particles packaged with a PSA promoter driven-suicide gene.

Authors:  Mien-Chun Lin; Meilin Wang; Ming-Chieh Chou; Chun-Nun Chao; Chiung-Yao Fang; Pei-Lain Chen; Deching Chang; Cheng-Huang Shen
Journal:  Cancer Gene Ther       Date:  2019-01-29       Impact factor: 5.854
  1 in total
  2 in total

1.  Long noncoding RNA LINC00963 induces NOP2 expression by sponging tumor suppressor miR-542-3p to promote metastasis in prostate cancer.

Authors:  Feng Sun; Ke Wu; Zhixian Yao; Xingyu Mu; Zhong Zheng; Menghao Sun; Yong Wang; Zhihong Liu; Yiyong Zhu
Journal:  Aging (Albany NY)       Date:  2020-06-17       Impact factor: 5.682

Review 2.  Single-Domain Antibody-Based TCR-Like CAR-T: A Potential Cancer Therapy.

Authors:  Lichen Zhu; Xiaomei Yang; Dani Zhong; Shenxia Xie; Wei Shi; Yangzi Li; Xiaoqiong Hou; Huihui Zhou; Minlong Zhao; Ziqiang Ding; Xinyue Zhao; Fengzhen Mo; Shihua Yin; Aiqun Liu; Xiaoling Lu
Journal:  J Immunol Res       Date:  2020-09-07       Impact factor: 4.818
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.